SHAPING THE FUTURE OF
n (Life Sciences & Allied Applications / Biology) the mimicking of life using imitation biological systems
Clinical Evaluation of the BioMimics 3D Stent: the MIMICS Study
Veryan has completed a multicenter, prospective, randomized (2:1) control trial, with a 24-month follow-up in subjects undergoing femoropopliteal intervention; the Mimics Study. (ClinicalTrials.gov identifier: NCT02163863).
After a 10 patient phase I lead-in, the Mimics study enrolled 76 patients in the phase II randomized trial; 50 patients received the non-planar BioMimics 3D stent and 26 patients received a straight Nitinol control stent. C.R. Bard’s LifeStent® was the most commonly used stent in the control arm (placed in 24/26 control cases). A core lab provided independent review and analysis of imaging data.
This study supported the CE Marking of BioMimics 3D.
The paper entitled Helical Centerline Stent Improves patency: Two-Year Results From the Randomized mimics Trial, authored by Professor Thomas Zeller MD, Professor Peter Gaines MD, Gary Ansel, MD and Professor Colin Caro was published in Circulation: Cardiovascular Interventions on May 20, 2016. To access the article, click here.